Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases
- 31 December 1997
- journal article
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 18, 169-179
- https://doi.org/10.1016/s0098-2997(97)00024-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Ubiquinone-10 Protects Neurons from Virus-Induced DegenerationJournal of Neurochemistry, 2002
- Elucidation of a tripartite mechanism underlying the improvement in cardiac tolerance to ischemia by coenzyme Q10 pretreatmentThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Aging, energy, and oxidative stress in neurodegenerative diseasesAnnals of Neurology, 1995
- Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonateAnnals of Neurology, 1994
- Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10Neuroscience Letters, 1994
- Ubisemiquinones as obligatory intermediates in the electron transfer from NADH to ubiquinoneEuropean Journal of Biochemistry, 1994
- An analysis of the role of coenzyme Q in free radical generation and as an antioxidantBiochemistry and Cell Biology, 1992
- Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Annals of Neurology, 1992
- Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)Acta Neurologica Scandinavica, 1991
- Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q 10Neurology, 1988